Best General Drug Manufacturer Stocks to Buy Now (2025)Top general drug manufacturer stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best general drug manufacturer stocks to buy now. Learn More.
Industry: Drug Manufacturers - Gene...
A
General Drug Manufacturers is Zen Rated A and is the 1st ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Zen Rating | Financials | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GRFS | GRIFOLS SA | $6.70B | 2.70% | 0.70% | 5.73% | 5.80% | 2.18 | 2.66 | 38.70% | 2.20% | 15.29% | ||
| GSK | GSK PLC | $81.99B | 24.20% | 5.80% | 12.18% | 16.10% | 3.04 | 0.87 | 71.40% | 10.80% | 14.97% | ||
| BIIB | BIOGEN INC | $21.24B | 9.00% | 5.40% | 7.15% | 15.70% | 0.61 | 2.50 | 75.40% | 15.30% | 17.98% | ||
| LLY | ELI LILLY & CO | $719.43B | 88.40% | 16.00% | 27.24% | 22.10% | 4.52 | 1.28 | 82.60% | 25.90% | 31.66% | ||
| SNY | SANOFI | $118.66B | 12.80% | 7.20% | 11.91% | 27.80% | 0.78 | 1.27 | 71.60% | 21.20% | 26.49% | ||
| AMRN | AMARIN CORP PLC | $301.97M | -21.20% | -15.00% | -20.11% | -26.80% | 0.44 | 3.26 | 37.50% | -47.20% | -44.38% | ||
| NVS | NOVARTIS AG | $237.09B | 32.60% | 13.30% | 23.01% | 40.10% | 1.49 | 0.82 | 76.20% | 24.70% | 30.30% | ||
| GILD | GILEAD SCIENCES INC | $139.29B | 32.90% | 11.20% | 18.42% | 23.70% | 1.84 | 1.32 | 78.50% | 21.90% | 28.42% | ||
| AZN | ASTRAZENECA PLC | $240.84B | 19.80% | 7.80% | 14.82% | 26.20% | 1.51 | 0.86 | 81.40% | 14.70% | 20.68% | ||
| BMY | BRISTOL MYERS SQUIBB CO | $93.94B | 29.60% | 5.40% | 9.80% | 10.50% | 4.43 | 1.21 | 70.30% | 10.60% | 13.79% | ||
| ABBV | ABBVIE INC | $390.07B | 142.10% | 2.70% | 5.67% | 8.40% | -750.38 | 0.74 | 70.90% | 6.50% | 9.48% | ||
| JNJ | JOHNSON & JOHNSON | $426.76B | 30.40% | 12.20% | 20.25% | 43.20% | 1.46 | 1.01 | 67.90% | 25.00% | 31.10% | ||
| PFE | PFIZER INC | $136.74B | 12.00% | 5.10% | 6.25% | 9.50% | 1.32 | 1.16 | 72.10% | 16.80% | 16.48% | ||
| SCLX | SCILEX HOLDING CO | $173.61M | N/A | -138.10% | 32.94% | 40.80% | -1.34 | 0.11 | 70.40% | -278.00% | -165.46% | ||
| AMGN | AMGEN INC | $147.89B | 97.90% | 7.40% | 15.37% | 14.40% | 10.83 | 1.31 | 64.50% | 19.00% | 29.68% | ||
| MRK | MERCK & CO INC | $202.67B | 34.90% | 14.00% | 22.33% | 26.50% | 1.40 | 1.42 | 76.60% | 25.80% | 32.11% | ||
| OGN | ORGANON & CO | $2.72B | 125.00% | 5.30% | 11.01% | 9.30% | 17.42 | 1.65 | 56.30% | 11.10% | 18.77% | ||
| NSRX | NASUS PHARMA LTD | N/A | N/A | N/A | 46.79% | N/A | -1.22 | 0.12 | N/A | N/A | N/A | ||
| MIRA | MIRA PHARMACEUTICALS INC | $24.60M | -406.70% | -328.40% | -1,375.94% | 2,456.50% | 0.52 | 2.79 | N/A | N/A | N/A |
General Drug Manufacturer Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.